Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07389538Not ApplicableRecruiting

Promoting Safe Medication Practices in the Classroom

Role: collaborator

NCT06514378Phase 1Recruiting

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Role: collaborator

NCT06423651Not ApplicableRecruiting

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

Role: collaborator

NCT05849636Not ApplicableUnknown

Alerta Cannabis: Evaluation of Web-based Tailored Intervention

Role: collaborator

All 4 trials loaded